An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Inclusion Criteria

• •The patient has completed the previous CLDT600A2407 study and is able to immediately enter this extension study with no study drug discontinuation
• •Patient is willing and able to comply with the study drug regimen and all other study requirements
• •The patient is willing and able to provide written informed consent to participate in the extension study.